115 related articles for article (PubMed ID: 25046029)
1. Use of genetic technologies to compare medicines.
Kolitz SE; Towfic F; Grossman I; Hayden MR; Zeskind B
Clin Genet; 2014 Nov; 86(5):441-6. PubMed ID: 25046029
[TBL] [Abstract][Full Text] [Related]
2. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Basic facts about biosimilars.
Nowicki M
Kidney Blood Press Res; 2007; 30(5):267-72. PubMed ID: 17622764
[TBL] [Abstract][Full Text] [Related]
5. Biosimilars: how similar or dissimilar are they?
Roger SD
Nephrology (Carlton); 2006 Aug; 11(4):341-6. PubMed ID: 16889575
[TBL] [Abstract][Full Text] [Related]
6. European regulatory guidelines for biosimilars.
Wiecek A; Mikhail A
Nephrol Dial Transplant; 2006 Oct; 21 Suppl 5():v17-20. PubMed ID: 16959790
[TBL] [Abstract][Full Text] [Related]
7. [The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors].
Jahnz-Rozyk K; Wiesik-Szewczyk E;
Pol Merkur Lekarski; 2014 Jul; 37(217):5-9. PubMed ID: 25154192
[TBL] [Abstract][Full Text] [Related]
8. Biosimilar medicines--new challenges for a new class of medicine.
Fox A
J Biopharm Stat; 2010 Jan; 20(1):3-9. PubMed ID: 20077245
[TBL] [Abstract][Full Text] [Related]
9. Biosimilars and regulatory authorities.
Minghetti P; Rocco P; Del Vecchio L; Locatelli F
Nephron Clin Pract; 2011; 117(1):c1-7. PubMed ID: 20689318
[TBL] [Abstract][Full Text] [Related]
10. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
11. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
12. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
13. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
14. Biosimilars: impact of biologic product life cycle and European experience on the regulatory trajectory in the United States.
Ahmed I; Kaspar B; Sharma U
Clin Ther; 2012 Feb; 34(2):400-19. PubMed ID: 22244050
[TBL] [Abstract][Full Text] [Related]
15. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
Lipworth W; Doran E; Kerridge I; Day R
Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
[TBL] [Abstract][Full Text] [Related]
16. Improving drug safety using computational biology.
Cook D
IDrugs; 2010 Feb; 13(2):85-9. PubMed ID: 20127559
[TBL] [Abstract][Full Text] [Related]
17. Biosimilars: current status and future directions.
Roger SD
Expert Opin Biol Ther; 2010 Jul; 10(7):1011-8. PubMed ID: 20384525
[TBL] [Abstract][Full Text] [Related]
18. The year's new drugs & biologics - 2008.
Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
[TBL] [Abstract][Full Text] [Related]
19. The year's new drugs and biologics--2007.
Graul AI; Prous JR; Barrionuevo M; Bozzo J; Castaner R; Cruces E; Revel L; Rosa E; Serradell N; Sorbera LA
Drug News Perspect; 2008; 21(1):7-35. PubMed ID: 18301807
[TBL] [Abstract][Full Text] [Related]
20. State of the art in benefit-risk analysis: medicines.
Luteijn JM; White BC; Gunnlaugsdóttir H; Holm F; Kalogeras N; Leino O; Magnússon SH; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; McCarron PA; Verhagen H
Food Chem Toxicol; 2012 Jan; 50(1):26-32. PubMed ID: 21683115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
